Field Trip Health (FTRP) Stock Price, News & Analysis

Company Overview

Field Trip Health Ltd. engages in the development and delivery of psychedelic- assisted therapies in North America. The company operates Field Trip Health Centres that provide psychedelic therapies; offers Field Trip Digital apps; operates Field Trip Discovery, a drug development division that develops the next generation of psychedelic molecules; and provides ketamine-assisted therapy for the treatment of depression, anxiety, addiction, and other conditions. Field Trip Health Ltd. was founded in 2008 and is headquartered in Toronto, Canada.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 97,451 shs
• Average Volume: 36,819 shs
• Market Capitalization: C$12.68 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

FTRP Stock Analysis - Frequently Asked Questions

How do I buy shares of Field Trip Health?

Shares of FTRP stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

What other stocks do shareholders of Field Trip Health own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Field Trip Health investors own include Meta Platforms (META), Alpha and Omega Semiconductor (AOSL), American Tower (AMT), Ambarella (AMBA), Applied Materials (AMAT), Akamai Technologies (AKAM) and C3.ai (AI).

Industry, Sector and Symbol

• Stock Exchange: TSE
• Sector: Medical
• Industry: Outpatient Mental Health & Substance Abuse Centers
• Sub-Industry: N/A
• Current Symbol: TSE:FTRP
• CIK: N/A
• Web: www.fieldtriphealth.com
• Phone: 833 222 0084
• Fax: N/A
• Employees: 104
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: 43.39
• Current Ratio: 8.20
• Quick Ratio: 7.70

Sales & Book Value

• Annual Sales: C$4.86 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: 0.98
• Book Value: C$1.15 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 11,630,000
• Free Float: N/A
• Market Cap: C$12.68 million
• Optionable: Not Optionable
• Beta: N/A